Sign Up For Free
Three areas of particular interest
Robust is one way to define the current breadth of research that involves the cannabis and its chemical parts. Across the planet – namely in states and countries where medical cannabis is permitted – scientists are becoming increasingly invested in discovering the full potential of the cannabis plant. To date, those studies have focussed tightly on the isolating and use of particular cannabinoids, and the prospect that isolated cannabis molecules may hold the key to any number of conditions. With these advancements, researchers have been able to add significant scientific knowledge, data and innovation to the medical cannabis discussion.
Easily the most important area of research for many cannabis researchers circles around CBD. Recent research has found that cannabidiol, a non-psychoactive cannabinoid, can help with everything from anxiety to inflammation, and high blood pressure to liver injury. The plethora of research that has focussed exclusively on this one cannabinoid is no short of impressive. CBD has gained real traction among patient advocates for its unprecedented ability to treat severe seizures in people grappling with the symptoms of epilepsy and Dravet syndrome. Where THC has for decades made cannabis easy to demonize, the strictly analgesic properties of CBD seem to have convinced many of the therapeutic merits of the plant’s extracts.1
Where cannabis researchers have been able to lend to the progress of the cannabis industry is in the advancements made in the lab in the area of concentrates. Traditionally, cannabis concentrates were produced using no solvent, or dangerous solvents. Research in the space has pushed the use of supercritical extractors to a new height. The result, pure solvent-less concentrates that are easy to dose, represent one of the most significant advancement in the space in recent years. In the context of new research, there is a direct correlation between science and the development of new medical products like sprays, lozenges and balms.
Isolated molecules
There are few areas of research that hold more promise for medical patients than that surrounding isolated cannabinoids. While these treatment options have been available for years, the efficacy of the products has been called into question. That said, there are dozens of top labs currently exploring research around isolated cannabis molecules. In years to come, speculation is that medical cannabis treatment may well be synonymous with the consumption of isolated molecules. A product that can treat a particular symptom or ailment, in a precise dose, would be a welcome addition to the roster of cannabis products currently available on the market. As the research progresses in the space, the likelihood of these studies lending to new advancements in the cannabis industry is guaranteed.

  1. The 17 most compelling studies on CBD from 2017. http://haleighshope.co/blog/17-compelling-studies-cbd-2017/
  2. Isolation of cannabinoids from the plant cannabis sativa and its potential anticancer activity. http://www.ijddr.in/drug-development/isolation-of-cannabinoids-from-the-plantcannabis-sativa-and-its-potential-anticancer-activity.php?aid=4976

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.


Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.